Updates 2025 EPS Guidance with $823M IPR&D Expense
In This Article:AbbVie Inc. (NYSE:ABBV) is one of the 7 most undervalued pot stocks to buy according to analysts. On July 3, the company provided an update to its 2025 earnings guidance to account fo…